Contact this trialFirst, we need to learn more about you.
RAF/MEK Inhibitor
Avutometinib +2 More for Colorectal Cancer
Recruiting1 awardPhase 2
Houston, Texas
"This trial is testing whether a combination of three drugs can help to control advanced colorectal cancer that cannot be surgically removed and has not responded to standard treatment."
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.